SynthesisPloS one2024

Evaluating the efficacy and safety of mavacamten in hypertrophic cardiomyopathy: A systematic review and meta-analysis focusing on qualitative assessment, biomarkers, and cardiac imaging.

Rahul Vyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.